North America Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implants, Tissue Expander), By Shape (Round, Anatomical), By End-use (Hospitals, Cosmetology Clinics) By Region And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 24 Business Hours
North America Breast Reconstruction Market Growth & Trends
The North America breast reconstruction market size is anticipated to reach USD 366.27 million by 2030, registering a CAGR of 6.69% during the forecast period, according to a new report by Grand View Research, Inc. This can be credited to the increase in number of breast cancer patients within this region. For instance, as per the Canadian Cancer Society 2019, one in eight females is expected to be diagnosed with breast cancer. Moreover, as per a similar source, breast cancer is the second most occurring cancer in Canada. Thus, the increasing number of breast cancer patients in Canada is predicted to boost the North America Breast Reconstruction market.
Moreover, the number of breast reconstruction surgery is also increasing in this region. For instance, as per the Archives of Plastic Surgery, post-mastectomy breast reconstruction surgery has increased from 19.4% in 2015 to 53.4% in 2018. Similarly, as per the Canadian Cancer Society, one in every five women in Canada goes under breast reconstruction post-mastectomy. Thus, a rise in the number of breast reconstruction surgery is anticipated to drive the North America breast reconstruction market.
Furthermore, the initiation of various awareness campaigns is leading to rising awareness among women. For instance, the Breast Reconstruction Awareness Campaign educates, engages & empowers females to take the right decision regarding breast reconstruction, post breast cancer diagnosis.
The North America breast reconstruction market witnessed a dip due to COVID-19. However, post-pandemic, the market is projected to have a significant growth rate. Elective surgeries such as breast augmentation, which were postponed during COVID-19, are expected to be held in the post-COVID-19 period. Moreover, to capture the market, many companies are entering into various strategies such as geographic expansion, product launches, and partnerships.
For instance, in April 2021, Sientra, Inc. and the Butterfly Network announced a strategic partnership to improve diagnostic surveillance of breast implant patients. This was expected to help the company to strengthen its safety profile, which was backed by the Platinum20 warranty program. Therefore, such instances are expected to drive the North America breast reconstruction market in the post-COVID-19 period.
North America Breast Reconstruction Market Report Highlights
North America Breast Reconstruction Market Growth & Trends
The North America breast reconstruction market size is anticipated to reach USD 366.27 million by 2030, registering a CAGR of 6.69% during the forecast period, according to a new report by Grand View Research, Inc. This can be credited to the increase in number of breast cancer patients within this region. For instance, as per the Canadian Cancer Society 2019, one in eight females is expected to be diagnosed with breast cancer. Moreover, as per a similar source, breast cancer is the second most occurring cancer in Canada. Thus, the increasing number of breast cancer patients in Canada is predicted to boost the North America Breast Reconstruction market.
Moreover, the number of breast reconstruction surgery is also increasing in this region. For instance, as per the Archives of Plastic Surgery, post-mastectomy breast reconstruction surgery has increased from 19.4% in 2015 to 53.4% in 2018. Similarly, as per the Canadian Cancer Society, one in every five women in Canada goes under breast reconstruction post-mastectomy. Thus, a rise in the number of breast reconstruction surgery is anticipated to drive the North America breast reconstruction market.
Furthermore, the initiation of various awareness campaigns is leading to rising awareness among women. For instance, the Breast Reconstruction Awareness Campaign educates, engages & empowers females to take the right decision regarding breast reconstruction, post breast cancer diagnosis.
The North America breast reconstruction market witnessed a dip due to COVID-19. However, post-pandemic, the market is projected to have a significant growth rate. Elective surgeries such as breast augmentation, which were postponed during COVID-19, are expected to be held in the post-COVID-19 period. Moreover, to capture the market, many companies are entering into various strategies such as geographic expansion, product launches, and partnerships.
For instance, in April 2021, Sientra, Inc. and the Butterfly Network announced a strategic partnership to improve diagnostic surveillance of breast implant patients. This was expected to help the company to strengthen its safety profile, which was backed by the Platinum20 warranty program. Therefore, such instances are expected to drive the North America breast reconstruction market in the post-COVID-19 period.
North America Breast Reconstruction Market Report Highlights
- In terms of product, the implants segment held the largest market share of 63.40% in 2021 in the North America breast reconstruction market. However, the tissue expander segment is expected to develop with the fastest growth rate of 6.85% CAGR, during the forecast period. This can be credited to the advancement in the products within the tissue expander segment
- Based on shape, the round shape segment held the largest share of 55.30% in 2021 in the North America breast reconstruction market. However, the anatomical shape is anticipated to witness the fastest growth rate of CAGR of 6.81% during the forecast period
- Based on end-use, the hospital segment was expected to dominate the market with a 55.28% share during 2021. However, the cosmetology clinics segment is projected to witness the highest growth rate of 6.91% CAGR during the forecast period. This can be credited to the rising number of cosmetologists in the North America region.
- Based on the region, the U.S. dominated the North America breast reconstruction market. This can be credited to the increase in number of breast cancer & breast reconstruction procedures within this nation
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 PRODUCT
1.1.2 SHAPE
1.1.3 END-USE
1.1.4 REGIONAL SCOPE
1.1.5 ESTIMATES AND FORECAST TIMELINE
1.2 Research Methodology
1.3 Information procurement
1.3.1 PURCHASED DATABASE:
1.3.2 GVR’S INTERNAL DATABASE
1.3.3 SECONDARY SOURCES
1.3.4 PRIMARY RESEARCH
1.3.5 DETAILS OF PRIMARY RESEARCH
1.4 Information or Data Analysis
1.4.1 DATA ANALYSIS MODELS
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 COMMODITY FLOW ANALYSIS (MODEL 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 VOLUME PRICE ANALYSIS (MODEL 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 OBJECTIVE
1.10.2 OBJECTIVE
1.10.3 OBJECTIVE
1.10.4 OBJECTIVE
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 NORTH AMERICA BREAST RECONSTRUCTION MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 PARENT MARKET OUTLOOK
3.1.2 ANCILLARY MARKET OUTLOOK
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 CONSUMER BEHAVIOR ANALYSIS
3.3.2 MARKET INFLUENCER ANALYSIS
3.4 List of Key End-users
3.5 Market Dynamics
3.5.1 MARKET DRIVER ANALYSIS
3.5.1.1 Rising number of breast cancer cases in the region
3.5.1.2 Increasing awareness & acceptability of breast reconstruction among women with breast cancer
3.5.1.3 Increasing number of breast reconstructive procedures
3.5.1.4 Technological advancements
3.5.1.5 Availability of suitable reimbursement policies
3.5.2 MARKET RESTRAINTS ANALYSIS
3.5.2.1 Increasing alternatives to breast reconstruction
3.5.2.2 Complication due to a breast implant
3.6 North America Breast Reconstruction: Market Analysis Tools
3.6.1 INDUSTRY ANALYSIS - PORTER’S FIVE FORCES ANALYSIS
3.6.2 SWOT ANALYSIS, BY PEST
3.7 Impact of COVID-19 on Market
CHAPTER 4 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2022& 2030
4.3 Segment Dashboard
4.4 North America Breast Reconstruction Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
4.5.1 IMPLANTS
4.5.1.1 Implants market, 2018-2030 (USD Million)
4.5.1.1.1 Silicone Breast Implants market, 2018-2030 (USD Million)
4.5.1.1.2 Saline Breast Implants market, 2018-2030 (USD Million)
4.5.2 TISSUE EXPANDER
4.5.2.1 Tissue expander market, 2018-2030 (USD Million)
4.5.2.1.1 Saline expander market, 2018-2030 (USD Million)
4.5.2.1.2 Air Tissue Expander market, 2018-2030 (USD Million)
4.5.3 ACELLULAR DERMAL MATRIX
4.5.3.1 Acellular dermal matrix market, 2018-2030 (USD Million)
CHAPTER 5 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENT ANALYSIS, BY SHAPE, 2018 - 2030 (USD MILLION)
5.1 Definition and Scope
5.2 Shape Market Share Analysis, 2022& 2030
5.3 Segment Dashboard
5.4 North America Breast Reconstruction Market, by Shape, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
5.5.1 ROUND SHAPE
5.5.1.1 Round market, 2018-2030 (USD Million)
5.5.2 ANATOMICAL SHAPE
5.5.2.1 Anatomical market, 2018-2030 (USD Million)
CHAPTER 6 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
6.1 Definition and Scope
6.2 End-use Market Share Analysis, 2022& 2030
6.3 Segment Dashboard
6.4 North America Breast Reconstruction Market, by End-use, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.5.1 HOSPITALS
6.5.1.1 Hospitals market, 2018-2030 (USD Million)
6.5.2 COSMETOLOGY CLINICS
6.5.2.1 Cosmetology clinics market, 2018-2030 (USD Million)
6.5.2 AMBULATORY SURGICAL CENTERS
6.5.2.1 Ambulatory surgical centers market, 2018-2030 (USD Million)
CHAPTER 7 NORTH AMERICA BREAST RECONSTRUCTION MARKET: REGIONAL MARKET ANALYSIS, BY PRODUCT, BY SHAPE, BY END-USE2018 - 2030 (USD MILLION)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Market Size, & Forecasts, Volume and Trend Analysis, 2022 to 2030
7.6 North America
7.6.1 NORTH AMERICA BREAST RECONSTRUCTION MARKET, 2018 - 2030 (USD MILLION)
7.6.2 U.S.
7.6.2.1 U.S. breast reconstruction market market, 2018 - 2030 (USD Million)
7.6.3 CANADA
7.6.3.1 Canada breast reconstruction market, 2018 - 2030 (USD Million)
CHAPTER 8 NORTH AMERICA BREAST RECONSTRUCTION MARKET - COMPETITIVE ANALYSIS
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Company Categorization
8.2.1 INNOVATORS
8.2.2 MARKET LEADERS
8.3 Vendor Landscape
8.3.1 KEY COMPANY MARKET SHARE ANALYSIS, 2021
8.3.2 MAJOR DEALS AND STRATEGIC ALLIANCES
8.3.2.1 New Product Launch
8.3.2.2 Expansion
8.3.2.3 Acquistion
8.3.3 MARKET ENTRY STRATEGIES
8.4 Company Profiles
8.4.1 MENTOR MEDICAL SYSTEMS B.V. (JOHNSON & JOHNSON)
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 ABBVIE (ALLERGAN INC.)
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 INTEGRA LFESCIENCS CORPORATION
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 SIENTRA, INC.
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 IDEAL IMPLANT INCROPORATED
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 STRYKER CORPORATION
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 ESTABLISHMENT LABS HOLDING, INC. (MOTIVA USA LLC)
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 RTI SURGICAL
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 MTF BIOLOGICS
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 SIA (SURGICAL INNOVATION ASSOCIATES)
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
8.4.11 TELA BIO, INC.
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Product benchmarking
8.4.11.4 Strategic initiatives
1.1 Market Segmentation and Scope
1.1.1 PRODUCT
1.1.2 SHAPE
1.1.3 END-USE
1.1.4 REGIONAL SCOPE
1.1.5 ESTIMATES AND FORECAST TIMELINE
1.2 Research Methodology
1.3 Information procurement
1.3.1 PURCHASED DATABASE:
1.3.2 GVR’S INTERNAL DATABASE
1.3.3 SECONDARY SOURCES
1.3.4 PRIMARY RESEARCH
1.3.5 DETAILS OF PRIMARY RESEARCH
1.4 Information or Data Analysis
1.4.1 DATA ANALYSIS MODELS
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 COMMODITY FLOW ANALYSIS (MODEL 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 VOLUME PRICE ANALYSIS (MODEL 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 OBJECTIVE
1.10.2 OBJECTIVE
1.10.3 OBJECTIVE
1.10.4 OBJECTIVE
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 NORTH AMERICA BREAST RECONSTRUCTION MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 PARENT MARKET OUTLOOK
3.1.2 ANCILLARY MARKET OUTLOOK
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 CONSUMER BEHAVIOR ANALYSIS
3.3.2 MARKET INFLUENCER ANALYSIS
3.4 List of Key End-users
3.5 Market Dynamics
3.5.1 MARKET DRIVER ANALYSIS
3.5.1.1 Rising number of breast cancer cases in the region
3.5.1.2 Increasing awareness & acceptability of breast reconstruction among women with breast cancer
3.5.1.3 Increasing number of breast reconstructive procedures
3.5.1.4 Technological advancements
3.5.1.5 Availability of suitable reimbursement policies
3.5.2 MARKET RESTRAINTS ANALYSIS
3.5.2.1 Increasing alternatives to breast reconstruction
3.5.2.2 Complication due to a breast implant
3.6 North America Breast Reconstruction: Market Analysis Tools
3.6.1 INDUSTRY ANALYSIS - PORTER’S FIVE FORCES ANALYSIS
3.6.2 SWOT ANALYSIS, BY PEST
3.7 Impact of COVID-19 on Market
CHAPTER 4 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2022& 2030
4.3 Segment Dashboard
4.4 North America Breast Reconstruction Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
4.5.1 IMPLANTS
4.5.1.1 Implants market, 2018-2030 (USD Million)
4.5.1.1.1 Silicone Breast Implants market, 2018-2030 (USD Million)
4.5.1.1.2 Saline Breast Implants market, 2018-2030 (USD Million)
4.5.2 TISSUE EXPANDER
4.5.2.1 Tissue expander market, 2018-2030 (USD Million)
4.5.2.1.1 Saline expander market, 2018-2030 (USD Million)
4.5.2.1.2 Air Tissue Expander market, 2018-2030 (USD Million)
4.5.3 ACELLULAR DERMAL MATRIX
4.5.3.1 Acellular dermal matrix market, 2018-2030 (USD Million)
CHAPTER 5 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENT ANALYSIS, BY SHAPE, 2018 - 2030 (USD MILLION)
5.1 Definition and Scope
5.2 Shape Market Share Analysis, 2022& 2030
5.3 Segment Dashboard
5.4 North America Breast Reconstruction Market, by Shape, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
5.5.1 ROUND SHAPE
5.5.1.1 Round market, 2018-2030 (USD Million)
5.5.2 ANATOMICAL SHAPE
5.5.2.1 Anatomical market, 2018-2030 (USD Million)
CHAPTER 6 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
6.1 Definition and Scope
6.2 End-use Market Share Analysis, 2022& 2030
6.3 Segment Dashboard
6.4 North America Breast Reconstruction Market, by End-use, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.5.1 HOSPITALS
6.5.1.1 Hospitals market, 2018-2030 (USD Million)
6.5.2 COSMETOLOGY CLINICS
6.5.2.1 Cosmetology clinics market, 2018-2030 (USD Million)
6.5.2 AMBULATORY SURGICAL CENTERS
6.5.2.1 Ambulatory surgical centers market, 2018-2030 (USD Million)
CHAPTER 7 NORTH AMERICA BREAST RECONSTRUCTION MARKET: REGIONAL MARKET ANALYSIS, BY PRODUCT, BY SHAPE, BY END-USE2018 - 2030 (USD MILLION)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Market Size, & Forecasts, Volume and Trend Analysis, 2022 to 2030
7.6 North America
7.6.1 NORTH AMERICA BREAST RECONSTRUCTION MARKET, 2018 - 2030 (USD MILLION)
7.6.2 U.S.
7.6.2.1 U.S. breast reconstruction market market, 2018 - 2030 (USD Million)
7.6.3 CANADA
7.6.3.1 Canada breast reconstruction market, 2018 - 2030 (USD Million)
CHAPTER 8 NORTH AMERICA BREAST RECONSTRUCTION MARKET - COMPETITIVE ANALYSIS
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Company Categorization
8.2.1 INNOVATORS
8.2.2 MARKET LEADERS
8.3 Vendor Landscape
8.3.1 KEY COMPANY MARKET SHARE ANALYSIS, 2021
8.3.2 MAJOR DEALS AND STRATEGIC ALLIANCES
8.3.2.1 New Product Launch
8.3.2.2 Expansion
8.3.2.3 Acquistion
8.3.3 MARKET ENTRY STRATEGIES
8.4 Company Profiles
8.4.1 MENTOR MEDICAL SYSTEMS B.V. (JOHNSON & JOHNSON)
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 ABBVIE (ALLERGAN INC.)
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 INTEGRA LFESCIENCS CORPORATION
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 SIENTRA, INC.
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 IDEAL IMPLANT INCROPORATED
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 STRYKER CORPORATION
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 ESTABLISHMENT LABS HOLDING, INC. (MOTIVA USA LLC)
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 RTI SURGICAL
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 MTF BIOLOGICS
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 SIA (SURGICAL INNOVATION ASSOCIATES)
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
8.4.11 TELA BIO, INC.
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Product benchmarking
8.4.11.4 Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America breast reconstruction market, by country, 2018 - 2030 (USD Million)
Table 4 North America breast reconstruction market, by product, 2018 - 2030 (USD Million)
Table 5 North America breast reconstruction market, by shape, 2018 - 2030 (USD Million)
Table 6 North America breast reconstruction market, by end-use, 2018 - 2030 (USD Million)
Table 7 U.S. breast reconstruction market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. breast reconstruction market, by shape, 2018 - 2030 (USD Million)
Table 9 U.S. breast reconstruction market, by end-use, 2018 - 2030 (USD Million)
Table 10 Canada abreast reconstruction market, by product, 2018 - 2030 (USD Million)
Table 11 Canada abreast reconstruction market, by shape, 2018 - 2030 (USD Million)
Table 12 Canada abreast reconstruction market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America breast reconstruction market, by country, 2018 - 2030 (USD Million)
Table 4 North America breast reconstruction market, by product, 2018 - 2030 (USD Million)
Table 5 North America breast reconstruction market, by shape, 2018 - 2030 (USD Million)
Table 6 North America breast reconstruction market, by end-use, 2018 - 2030 (USD Million)
Table 7 U.S. breast reconstruction market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. breast reconstruction market, by shape, 2018 - 2030 (USD Million)
Table 9 U.S. breast reconstruction market, by end-use, 2018 - 2030 (USD Million)
Table 10 Canada abreast reconstruction market, by product, 2018 - 2030 (USD Million)
Table 11 Canada abreast reconstruction market, by shape, 2018 - 2030 (USD Million)
Table 12 Canada abreast reconstruction market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 North America breast reconstruction market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2021)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 North America breast reconstruction market: Product movement analysis
Fig. 19 Segment dashboard
Fig. 20 North America breast reconstruction market product outlook: Key takeaways
Fig. 21 Implants market, 2018 - 2030 (USD Million)
Fig. 22 Silicone breast implants market, 2018 - 2030 (USD Million)
Fig. 23 Saline breast implants market, 2018 - 2030 (USD Million)
Fig. 24 Tissue expander market, 2018 - 2030 (USD Million)
Fig. 25 Saline expander market, 2018 - 2030 (USD Million)
Fig. 26 Air tissue expander market, 2018 - 2030 (USD Million)
Fig. 27 Acellular dermal matrix market, 2018 - 2030 (USD Million)
Fig. 28 North America breast reconstruction market shape outlook: Key takeaways
Fig. 29 Roundshape market, 2018 - 2030 (USD Million)
Fig. 30 Anatomicalshape market, 2018 - 2030 (USD Million)
Fig. 31 North America breast reconstruction market end-use outlook: Key takeaways
Fig. 32 Hospitals market, 2018 - 2030 (USD Million)
Fig. 33 Cosmetology clinics market, 2018 - 2030 (USD Million)
Fig. 34 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
Fig. 35 Regional outlook, 2022 & 2030
Fig. 36 Regional market dashboard
Fig. 37 Regional market place: Key takeaways
Fig. 38 North America breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 39 U.S. breast reconstrcution market, 2018 - 2030 (USD Million)
Fig. 40 Canada breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 41 Company market share analysis, 2021
Fig. 42 Market differentiators
Fig. 43 Regional network map
Fig. 1 North America breast reconstruction market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2021)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 North America breast reconstruction market: Product movement analysis
Fig. 19 Segment dashboard
Fig. 20 North America breast reconstruction market product outlook: Key takeaways
Fig. 21 Implants market, 2018 - 2030 (USD Million)
Fig. 22 Silicone breast implants market, 2018 - 2030 (USD Million)
Fig. 23 Saline breast implants market, 2018 - 2030 (USD Million)
Fig. 24 Tissue expander market, 2018 - 2030 (USD Million)
Fig. 25 Saline expander market, 2018 - 2030 (USD Million)
Fig. 26 Air tissue expander market, 2018 - 2030 (USD Million)
Fig. 27 Acellular dermal matrix market, 2018 - 2030 (USD Million)
Fig. 28 North America breast reconstruction market shape outlook: Key takeaways
Fig. 29 Roundshape market, 2018 - 2030 (USD Million)
Fig. 30 Anatomicalshape market, 2018 - 2030 (USD Million)
Fig. 31 North America breast reconstruction market end-use outlook: Key takeaways
Fig. 32 Hospitals market, 2018 - 2030 (USD Million)
Fig. 33 Cosmetology clinics market, 2018 - 2030 (USD Million)
Fig. 34 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
Fig. 35 Regional outlook, 2022 & 2030
Fig. 36 Regional market dashboard
Fig. 37 Regional market place: Key takeaways
Fig. 38 North America breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 39 U.S. breast reconstrcution market, 2018 - 2030 (USD Million)
Fig. 40 Canada breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 41 Company market share analysis, 2021
Fig. 42 Market differentiators
Fig. 43 Regional network map
